Detalhe da pesquisa
1.
[We must respect the anti-SARS-CoV-2 vaccine schedule without delay in cancer patients under treatment]. / Nous devons respecter le schéma vaccinal anti-SARS-CoV-2 sans décalage chez les patients atteints de cancer sous traitement.
Bull Cancer
; 108(4): 341-342, 2021 Apr.
Artigo
em Francês
| MEDLINE | ID: mdl-33741139